ICAM‐1 expression in tumor tissues was elevated in wild‐type CT26 treated with anti‐PD‐1 compared to the control group; however, no significant change was observed in ICAM‐1‐depleted CT26 (Figure 1f). Here, DDX53 is linked to neoplasm.